372 related articles for article (PubMed ID: 19843474)
1. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.
Mann J; Chu DC; Maxwell A; Oakley F; Zhu NL; Tsukamoto H; Mann DA
Gastroenterology; 2010 Feb; 138(2):705-14, 714.e1-4. PubMed ID: 19843474
[TBL] [Abstract][Full Text] [Related]
2. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis.
Mann J; Oakley F; Akiboye F; Elsharkawy A; Thorne AW; Mann DA
Cell Death Differ; 2007 Feb; 14(2):275-85. PubMed ID: 16763620
[TBL] [Abstract][Full Text] [Related]
3. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
[No Abstract] [Full Text] [Related]
4. Paeoniflorin promotes PPARγ expression to suppress HSCs activation by inhibiting EZH2-mediated histone H3K27 trimethylation.
Lan T; Li P; Zhang SJ; Liu SY; Zeng XX; Chai F; Tong YH; Mao ZJ; Wang SW
Phytomedicine; 2024 Jun; 128():155477. PubMed ID: 38489890
[TBL] [Abstract][Full Text] [Related]
5. SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice.
Li M; Hong W; Hao C; Li L; Wu D; Shen A; Lu J; Zheng Y; Li P; Xu Y
FASEB J; 2018 Jan; 32(1):500-511. PubMed ID: 28970250
[TBL] [Abstract][Full Text] [Related]
6. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
7. Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate Cells.
Moran-Salvador E; Garcia-Macia M; Sivaharan A; Sabater L; Zaki MYW; Oakley F; Knox A; Page A; Luli S; Mann J; Mann DA
Gastroenterology; 2019 Nov; 157(5):1398-1412.e9. PubMed ID: 31352003
[TBL] [Abstract][Full Text] [Related]
8. Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells.
Kweon SM; Chi F; Higashiyama R; Lai K; Tsukamoto H
PLoS One; 2016; 11(5):e0156111. PubMed ID: 27214381
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation and MeCP2 regulation of PTCH1 expression during rats hepatic fibrosis.
Yang JJ; Tao H; Huang C; Shi KH; Ma TT; Bian EB; Zhang L; Liu LP; Hu W; Lv XW; Li J
Cell Signal; 2013 May; 25(5):1202-11. PubMed ID: 23333245
[TBL] [Abstract][Full Text] [Related]
10. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ.
Du Z; Liu M; Wang Z; Lin Z; Feng Y; Tian D; Xia L
Cell Prolif; 2021 Jul; 54(7):e13072. PubMed ID: 34031939
[TBL] [Abstract][Full Text] [Related]
11. Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor γ in hepatic stellate cells for their antifibrotic effect.
Yang MD; Chiang YM; Higashiyama R; Asahina K; Mann DA; Mann J; Wang CC; Tsukamoto H
Hepatology; 2012 Apr; 55(4):1271-81. PubMed ID: 22095555
[TBL] [Abstract][Full Text] [Related]
12. A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A.
Zeybel M; Luli S; Sabater L; Hardy T; Oakley F; Leslie J; Page A; Moran Salvador E; Sharkey V; Tsukamoto H; Chu DCK; Singh US; Ponzoni M; Perri P; Di Paolo D; Mendivil EJ; Mann J; Mann DA
Mol Ther; 2017 Jan; 25(1):218-231. PubMed ID: 28129116
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis.
Zhao Q; Qin CY; Zhao ZH; Fan YC; Wang K
Tohoku J Exp Med; 2013 Jan; 229(1):35-43. PubMed ID: 23238615
[TBL] [Abstract][Full Text] [Related]
14. Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.
Liu X; Xu J; Rosenthal S; Zhang LJ; McCubbin R; Meshgin N; Shang L; Koyama Y; Ma HY; Sharma S; Heinz S; Glass CK; Benner C; Brenner DA; Kisseleva T
Gastroenterology; 2020 May; 158(6):1728-1744.e14. PubMed ID: 31982409
[TBL] [Abstract][Full Text] [Related]
15. MeCP2 epigenetically regulates alpha-smooth muscle actin in human lung fibroblasts.
Xiang Z; Zhou Q; Hu M; Sanders YY
J Cell Biochem; 2020 Jul; 121(7):3616-3625. PubMed ID: 32115750
[TBL] [Abstract][Full Text] [Related]
16. The role of methyl-CpG binding protein 2 in liver fibrosis.
Bian EB; Huang C; Wang H; Chen XX; Tao H; Zhang L; Lv XW; Li J
Toxicology; 2013 Jul; 309():9-14. PubMed ID: 23619607
[TBL] [Abstract][Full Text] [Related]
17. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH
Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787
[TBL] [Abstract][Full Text] [Related]
18. Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and liver fibrosis by epigenetically regulating peroxisome proliferator-activated receptor γ.
Jiang Y; Wang S; Zhao Y; Lin C; Zhong F; Jin L; He F; Wang H
FASEB J; 2015 May; 29(5):1830-41. PubMed ID: 25609425
[TBL] [Abstract][Full Text] [Related]
19. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis.
Coward WR; Feghali-Bostwick CA; Jenkins G; Knox AJ; Pang L
FASEB J; 2014 Jul; 28(7):3183-96. PubMed ID: 24652950
[TBL] [Abstract][Full Text] [Related]
20. IUGR differentially alters MeCP2 expression and H3K9Me3 of the PPARγ gene in male and female rat lungs during alveolarization.
Joss-Moore LA; Wang Y; Ogata EM; Sainz AJ; Yu X; Callaway CW; McKnight RA; Albertine KH; Lane RH
Birth Defects Res A Clin Mol Teratol; 2011 Aug; 91(8):672-81. PubMed ID: 21425435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
